Related Experiment Video
Updated: Apr 19, 2026
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
[Informed consent for patients undergoing surgery for ischemic cardiomyopathy]
1Department of Cardiovascular Surgery, Saitama Medical Center, Japan.
Insights
Patients with ischemic cardiomyopathy have a poor prognosis and high surgical risks. Current guidelines suggest careful evaluation for combined procedures like myocardial revascularization with surgical ventricular reconstruction or mitral valve plasty.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Treatment
Context:
- Ischemic cardiomyopathy (ICM) presents a significant challenge with poor prognosis despite medical advancements.
- Patients with ICM often face elevated operative risks, complicating surgical decision-making.
- Managing ICM patients without angina is particularly difficult due to limited evidence-based guidelines.
Purpose:
- To review the current understanding and challenges in managing patients with ischemic cardiomyopathy.
- To evaluate the efficacy of combined surgical procedures versus isolated myocardial revascularization in ICM.
- To highlight the importance of expert surgical evaluation for complex cardiac interventions in ICM.
Summary:
- Despite advances, ischemic cardiomyopathy prognosis remains poor, with high operative risks.
- Established indications for revascularization in ICM focus on patients with angina; those without are challenging.
- Combined procedures (myocardial revascularization with surgical ventricular reconstruction or mitral valve plasty) show limited long-term outcome differences compared to simple revascularization.
Impact:
- This review underscores the need for careful patient selection and surgical expertise in managing ischemic cardiomyopathy.
- It emphasizes the challenges in treating ICM patients without angina, calling for further research.
- Findings inform clinical practice regarding the complex decision-making process for surgical interventions in ischemic heart failure.
Abstract:
The prognosis of patients with ischemic cardiomyopathy after medical treatment remains poor, despite advances in various therapeutic strategies. In addition to the poorer prognosis, they face higher operative risk, and complex, unestablished operative procedures should be addressed when obtaining preoperative informed consent from patients with ischemic cardiomyopathy. Although the established indications for revascularization in patients with ischemic heart failure pertain to those with angina and significant coronary artery disease, the management of patients with ischemic heart failure without angina is a challenge because of the lack of evidence in this population. The possibility of combining myocardial revascularization with surgical ventricular reconstruction (SVR) to reverse left ventricular remodeling or with mitral valve plasty to repair the incompetence of mitral valve coaptation has been examined in many trials, although little difference in the long-term outcomes between the simple revascularization and the combined procedure groups have been observed. The therapeutic guidelines for patients with ischemic cardiomyopathy state that choosing to add SVR and/or mitral surgery to revascularization should be based on a precise, careful evaluation and should be performed only by surgeons with a high level of surgical expertise.
More Related Videos
Related Concept Videos
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
01:29Cardiomyopathy V: Interprofessional Care
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:28Cardiac Catheterization I: Pre-Procedure Overview
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...